Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, is excited to announce its participation in the ...

Nexalin's Sync neurostimulation device uses a specific electrical waveform to increase hippocampal-cortical connectivity. The device has already been approved in China to treat depression and insomnia ...

Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency ...

Rapid, combined and personalized non-invasive stimulation of the precuneus improves associative memory, enhances local gamma expression, and strengthens precuneus–hippocampal connectivity.

A new type of noninvasive brain stimulation may help people with moderate to severe depression feel better faster than standard treatments, researchers in a new report say. The method, called ...

A new study shows that a personalized, precise form of brain stimulation, HD-tDCS, can rapidly ease depression symptoms – and even reduce anxiety – offering a promising drug-free alternative with only ...

A new study explores personalized deep brain stimulation for chronic pain sufferers, offering hope for those unresponsive to traditional treatments. Researchers implanted electrodes, identified ...

The INTREPID study group, a team of 49 researchers from 30 academic and medical institutions, reports on sustained five-year benefits from subthalamic nucleus deep brain stimulation for Parkinson's ...